copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
RYTELO® (imetelstat) HCP Website | RYTELOHCP RYTELO® (imetelstat) is indicated for treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia
DailyMed - RYTELO- imetelstat sodium injection, powder . . . RYTELO for injection contains imetelstat, an oligonucleotide telomerase inhibitor for intravenous use Imetelstat sodium is a white to off-white or slightly yellow, amorphous, solid powder
Rytelo (imetelstat) dosing, indications, interactions . . . Medscape - Myelodysplastic syndrome dosing for Rytelo (imetelstat), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information
RYTELO (imetelstat), FDA Approved for Treatment of Patients . . . Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Geron Corporation as a limited specialty pharmacy provider for RYTELOTM (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring four or more red blood cell units over eight
label - Food and Drug Administration RYTELO (imetelstat) for injection is a sterile, preservative-free, white to off-white or slightly yellow lyophilized powder for intravenous infusion after reconstitution and dilution
Rytelo: Uses, Dosage, Side Effects, Warnings - Drugs. com Rytelo (imetelstat) is an injectable telomerase inhibitor that may be used to treat adults with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia
Imetelstat (RYTELO) National Drug Mini-Monograph July 2025 References RYTELO (imetelstat) for intravenous injection [prescribing information online] Foster City, CA: Geron Corporation 6 2024 Available at: rytelo_pi pdf Accessed 12 9 2024